Latest News about NVS
Recent news which mentions NVS
   CLVS Stock Alert: What to Know as Clovis Oncology Files for Bankruptcy
   
  
  
  December 12, 2022
  From InvestorPlace
 
   Erasca Oulicenses Its Mid-Stage Cancer Program To Novartis, Raises $100M Via Equity Offering
   
  
  
  December 09, 2022
  From Benzinga
 
   Novartis' Rare Blood Disorder Therapy Aces Second Late-Stage Trial
   
  December 08, 2022
  Tickers 
   NVS
  
  
  From Benzinga
 
   3 Hot Stocks That Could Live Up to Their Lofty Valuations
   
  
  
  December 08, 2022
  From Motley Fool
 From Benzinga
 
   Novartis' Kisqali Prolongs Progression Free Survival Benefit In Metastatic Breast Cancer Versus Chemo
   
  December 07, 2022
  Tickers 
   NVS
  
  
  From Benzinga
 
   Novartis prostate cancer drug trial meets primary endpoint
   
  December 05, 2022
  Tickers 
   NVS
  
  
  From MarketWatch
 
   Mirati Plays Catch-Up With Amgen, Gilead's 2nd Try With AIDS Drug, Cytokinetics' Adcom Test And More: Key Nov FDA Decisions For Biotech Investors
   
  
  
  December 02, 2022
  From Benzinga
 
   10 Health Care Stocks Whale Activity In Today's Session
   
  
  
  November 28, 2022
  From Benzinga
 
   3 Biotech Stocks Smart Investors Should Be Buying Up Now
   
  
  
  November 24, 2022
  From InvestorPlace
 
   Novartis' Malaria Treatment Candidate To Move Forward With Phase 3 Development Next Year
   
  November 23, 2022
  Tickers 
   NVS
  
  
  From Benzinga
 
   10 Health Care Stocks Whale Activity In Today's Session
   
  
  
  November 22, 2022
  From Benzinga
 
   First Patients Dosed in Phase I/II Trial of Enlivex's Off-the-Shelf Cell Therapy Candidate, AllocetraTM
   
  
  
  November 22, 2022
  From Benzinga
 
   TEVA Stock Alert: What to Know About Teva Pharmaceuticals’ New CEO
   
  
  
  November 21, 2022
  From InvestorPlace
 
   2 Top Biotech Stocks to Buy Right Now
   
  
  
  November 19, 2022
  From Motley Fool
 
   10 Health Care Stocks Whale Activity In Today's Session
   
  
  
  November 17, 2022
  From Benzinga
 
   BioNTech Plans To Set Up Singapore Based mRNA Plant By End Of 2023
   
  
  
  November 14, 2022
  From Benzinga
 
   Should Income Investors Buy This High-Yielding Dividend Stock?
   
  November 13, 2022
  Tickers 
   NVS
  
  
  From Motley Fool
 
   2 Biotech Stocks That Could Make You Richer
   
  
  
  November 04, 2022
  From Motley Fool
 
   After FDA, European Agency Limits Use Of Certain JAK Inhibitors Amid Safety Concerns
   
  
  
  October 31, 2022
  From Benzinga
 
   3 High-Yielding Dividend Stocks That You Can Buy and Hold Forever
   
  
  
  October 27, 2022
  From Motley Fool
 
   Twitter Considers Crypto Wallet, Geopolitical Woes To Keep Tesla Shares Volatile, Juul Explores Possible Bailout: Top Stories Tuesday, Oct. 25
   
  
  
  October 25, 2022
  From Benzinga
 From Motley Fool
 
   US Stock Futures Down; Big Tech Earnings In Focus
   
  
  
  October 25, 2022
  From Benzinga
 
   Novartis Clocks 4% Drop In Quarterly Sales, Once Again Perks Up Sandoz Earnings Outlook
   
  October 25, 2022
  Tickers 
   NVS
  
  
  From Benzinga
 
   Earnings Scheduled For October 25, 2022
   
  
  
  October 25, 2022
  From Benzinga
 Tickers 
   NVS
  
  
  From MarketWatch
 
   Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  
  
 Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  © 2025 FinancialContent. All rights reserved.
 

